Hypertonic saline aerosol increases airway reactivity in the canine lung periphery.
Hyperventilation with dry air increases airway surface fluid (ASF) osmolality and causes acute mucosal injury, leukocyte infiltration, and delayed airway obstruction and hyperreactivity in canine peripheral airways. The purpose of this study was to determine whether ASF hypertonicity per se can account for these hyperventilation-associated effects. We first measured ASF osmolality before and after normal (NSC) and hypertonic (HSC) saline aerosol challenges to document the magnitude of hypertonicity produced by these stimuli. We then measured canine peripheral airway resistance and reactivity to hypocapnia and aerosolized histamine before and after NSC and HSC. Cells and eicosanoid mediators recovered in bronchoalveolar lavage fluid at 5 and 24 h after NSC and HSC were examined. We found that HSC but not NSC caused acute ASF hyperosmolality, increased mediator release, and delayed airway hyperreactivity in the absence of mucosal injury and leukocyte infiltration. These observations suggest that ASF hyperosmolality contributes to the development of the late-phase response to hyperventilation and further suggest that hyperventilation-induced mucosal injury independently initiates leukocyte infiltration and late-phase airway obstruction.
Suzuki
R
R
Department of Environmental Health Sciences, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205, USA.
Freed
A N
AN
D000336:Aerosols; D000403:Airway Resistance; D000818:Animals; D001826:Body Fluids / Q000378:metabolism; D016535:Bronchial Hyperreactivity / Q000139:chemically induced* / Q000209:etiology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D004285:Dogs; D015777:Eicosanoids / Q000378:metabolism; D006632:Histamine / Q000008:administration & dosage; D016857:Hypocapnia / Q000150:complications / Q000503:physiopathology; D009994:Osmolar Concentration; D020545:Respiratory Mucosa / Q000378:metabolism; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage*
D000336:Aerosols; D015777:Eicosanoids; D012462:Saline Solution, Hypertonic; D006632:Histamine